PT Merck Tbk (IDX:MERK)

Indonesia flag Indonesia · Delayed Price · Currency is IDR
4,330.00
+200.00 (4.84%)
Apr 29, 2026, 9:29 AM WIB
23.01%
Market Cap 1.85T
Revenue (ttm) 1.20T
Net Income (ttm) 243.90B
Shares Out 448.00M
EPS (ttm) 544.41
PE Ratio 7.59
Forward PE n/a
Dividend 170.00 (4.43%)
Ex-Dividend Date Jun 25, 2025
Volume 106,400
Average Volume 89,785
Open 4,150.00
Previous Close 4,130.00
Day's Range 4,150.00 - 4,380.00
52-Week Range 2,720.00 - 4,350.00
Beta -0.11
RSI 84.43
Earnings Date Apr 2, 2026

About PT Merck Tbk

PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally. The company operates through Biopharma, Consumer Health, and Others segments. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in research an, development, production, and distribution of pharmaceutical and biological prescription medicines to treat colorectal cancer, head and neck cancer, m... [Read more]

Sector Healthcare
Founded 1970
Employees 364
Stock Exchange Indonesia Stock Exchange
Ticker Symbol MERK
Full Company Profile

Financial Performance

In 2025, PT Merck Tbk's revenue was 1.20 trillion, an increase of 15.81% compared to the previous year's 1.04 trillion. Earnings were 243.90 billion, an increase of 58.93%.

Financial Statements

News

There is no news available yet.